Skip to main content

Adenovirus

2
Pipeline Programs
5
Companies
5
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
375%
Vaccine
125%
+ 2 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
1
cytotoxic t-lymphocytesPhase 21 trial
Active Trials
NCT03266627Recruiting20Est. Dec 2027
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
1
cytotoxic t-lymphocytesPhase 2
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
3 programs
BrincidofovirN/ASmall Molecule1 trial
BrincidofovirN/ASmall Molecule1 trial
BrincidofovirPHASE_2Small Molecule1 trial
Active Trials
NCT02596997No Longer Available
NCT02420080Terminated100Est. Sep 2016
NCT03532035Withdrawn0Est. May 2019
Teva
TevaIsrael - Petach Tikva
1 program
Adenovirus Vaccine Pregnancy RegistryN/AVaccine1 trial
Active Trials
NCT01584037Withdrawn0Est. Apr 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Jazz PharmaceuticalsBrincidofovir
Angeles Therapeuticscytotoxic t-lymphocytes
Jazz PharmaceuticalsBrincidofovir
TevaAdenovirus Vaccine Pregnancy Registry

Clinical Trials (5)

Total enrollment: 120 patients across 5 trials

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

Start: Dec 2018Est. completion: May 20190
Phase 2Withdrawn
NCT03266627Angeles Therapeuticscytotoxic t-lymphocytes

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Start: Nov 2018Est. completion: Dec 202720 patients
Phase 2Recruiting

Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

N/ANo Longer Available

A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304

Start: Feb 2015Est. completion: Sep 2016100 patients
N/ATerminated
NCT01584037TevaAdenovirus Vaccine Pregnancy Registry

Adenovirus Vaccine Pregnancy Registry

Start: Dec 2011Est. completion: Apr 20140
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 120 patients
Small Molecule is the dominant modality (75% of programs)
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.